Formulations of sustained release matrix tablets of Furosemide using natural and synthetic polymers

Authors

  • Shivani Soni Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001
  • Vivek Jain Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001
  • Sunil Kumar Jain Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001
  • Pushpendra Kumar Khangar Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Abstract

The primary benefit of a sustained release dosage form compared to a conventional dosage form, is the consistent drug plasma concentration and consequently uniform therapeutic effect. Matrix system are preferential because of their ease, patient compliance etc, than  traditional drug delivery which have several drawbacks like reiterated administration, variation in blood concentration level etc. The aim of the present research study was to develop and evaluate sustained release matrix tablets of furosemide using direct compression method using  natural  gummy  and  waxy  materials (Xanthan  gum, bees  wax)  and synthetic  polymers  (HPMC K4M). The matrix tablet formulations were prepared by using different drug: polymer ratios (1:1, 1:2 and 1:3). All formulations were assessed using micromeritics studies of powder blend and diverse physicochemical tests. All the physicochemical characters of the formulated tablets were within acceptable limits. The release pattern of the drug was viewed over a period of 12 hours and determined the amount of drug by the UV-Visible spectroscopic method. Dissolution data demonstrated that the formulated tablets with Xanthan gum and hydroxyl propyl methylcellulose (HPMC) provided sustained release of the drug up to 12 hrs. Therefore inexpensively it may be appropriate for the pharmaceutical industries to employ this kind of simple technologies for the expansion of advanced formulations. Hence, we conclude that the purpose of this study was to formulate a sustained release matrix tablet of furosemide using diverse polymers and their dissimilar proportions have been attained.

Keywords: Furosemide, Direct compression, Natural, Synthetic polymers, Sustained release tablets.

Keywords:

Furosemide, Direct compression, Natural, Synthetic polymers, Sustained release tablets

DOI

https://doi.org/10.22270/jddt.v11i5.5122

Author Biographies

Shivani Soni, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Vivek Jain, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Sunil Kumar Jain, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Pushpendra Kumar Khangar, Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

Adina Institute of Pharmaceutical Science, NH86A, Lahdara, Sagar, MP 470001

References

Advanced oral and parenteral drug delivery technologies: Players, products & prospects to 2015. Dublin: Espicom Business Intelligence Ltd, 2011.

Charman SA, Charman W. Oral modified-release delivery systems. In: Rathbone, M.J.; Hadgraft, J.; Roberts, M.S. (Eds.). Modified-release drug delivery technology. New York: Marcel Dekker, 2002. chap. 1. https://doi.org/10.1201/9780203910337.pt1

Moodley K, PillaryV, ChoonaraYE, Toit LC, Ndesendo VMK, Kumar, P et al., Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery. Int J Mol Sci 2012; 13:18-43. https://doi.org/10.3390/ijms13010018

Malmsten M. Surfactants and polymers in drug delivery. Stockholm: Marcel Dekker, 2002; 335. https://doi.org/10.1201/9780824743758

Qiu LY, Bae, YH. Polymer architecture and drug delivery. Pharmac Res 2006; 23(1):1-30. https://doi.org/10.1007/s11095-005-9046-2

Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodrigez F, Heinamaki J. Development and optimization of a novel sustained release dextran tablet formulation for propranolol hydrochloride. Int J Pharm 2006; 317(1):32-39. https://doi.org/10.1016/j.ijpharm.2006.02.049

Lopez CM, Lobo JMS, Pinto JF, Costa P. Compressed minitablets as a biphasic delivery system. Int J Pharm 2006; 323:93- 100. https://doi.org/10.1016/j.ijpharm.2006.05.063

Varshosaz J, Tavakoli N, Eram SA. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets. Drug Del 2006; 13(2):113-119. https://doi.org/10.1080/10717540500313356

Onyechi JO, Okafo SE. Evaluation of carnauba wax in sustained release diclofenac sodium tablet formulation. J Chem Pharm Res 2016; 8(3):714-21.

Nart V, Beringhs AO, França MT, de Espíndola B, Pezzini BR, Stulzer HK. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs. Mater Sci Eng: C. 2017; 70:250-7. https://doi.org/10.1016/j.msec.2016.07.070

Gwen MJ, Joseph RR, Rhodes CT. Modern Pharmaceutics, Marcel Dekker, Inc., New York. 1996; 72(3):581.

Al Remawi M, Al-Akayleh F, Salem MS, Al Shami M, Badwan A. Application of an excipient made from chitosan and xanthan gum as a single component for the controlled release of Ambroxol. J Excipients Food Chem 2016; 4(2):1087-9.

Jain KK. Drug delivery systems. 1st edition. Switzerland: Human Press; 2008. pp 1-51. https://doi.org/10.1007/978-1-59745-210-6_1

Sakore S, Chakraborty B. Formulation and evaluation of enalapril maleate sustained release matrix tablets. Int J Pharm Biomed Res 2013; 4:21-6.

Udayakumar T, Suresh AG, Ubaidulla U. Formulation and evaluation of immediate and sustained release bilayered tablet with glibenclamide and metformin Hcl. Int J Res Dev Pharm Sci 2013; 2:337-43.

Shashidhar P, Vidya Sagar G, Srikanth G. Design and in-vitro evaluation of metformin hydrochloride (SR) and glimepiride (IR) as bilayered tablets. Int J Pharm Chem Sci 2013; 2:780-92.

Sridhar Babu G, Vijay Kumar D, Aishwarya M, Malathy PS, Redya Naik R. Formulation and in vitro characterization of sustained release matrix tablets of metformin Hcl. J Glob Trends Pharm Sci 2014; 5:2085-92.

Saluja V, Garg C. Once-daily sustained-release matrix tablets of metformin hydrochloride based on an enteric polymer and chitosan. J Pharm Educ Res 2013; 4:92-7.

Salsa T, Veiga F, Pina ME. Oral controlled-release dosage forms. i. cellulose ether polymers in hydrophilic matrices Drug Dev Ind Pharm. 1997; 23:929-938. https://doi.org/10.3109/03639049709148697

Published

2021-12-07
Statistics
Abstract Display: 912
PDF Downloads: 664
PDF Downloads: 217

How to Cite

1.
Soni S, Jain V, Jain SK, Khangar PK. Formulations of sustained release matrix tablets of Furosemide using natural and synthetic polymers. J. Drug Delivery Ther. [Internet]. 2021 Dec. 7 [cited 2026 Feb. 2];11(5):105-9. Available from: https://www.jddtonline.info/index.php/jddt/article/view/5122

How to Cite

1.
Soni S, Jain V, Jain SK, Khangar PK. Formulations of sustained release matrix tablets of Furosemide using natural and synthetic polymers. J. Drug Delivery Ther. [Internet]. 2021 Dec. 7 [cited 2026 Feb. 2];11(5):105-9. Available from: https://www.jddtonline.info/index.php/jddt/article/view/5122

Most read articles by the same author(s)

> >>